(Q39294174)

10 September 2017

title

Distinct cellular fates for KP1019 and NAMI-A determined by X-ray fluorescence imaging of single cells (English)

1 reference

10 September 2017

1 reference

ChEBI release 2020-05-28

Claire M Weekley

3

0 references

Hugh H. Harris

object named as

Hugh H Harris

6

0 references

author name string

Jade B Aitken

1

1 reference

10 September 2017

Sumy Antony

2

1 reference

10 September 2017

Barry Lai

4

1 reference

10 September 2017

Leone Spiccia

5

1 reference

10 September 2017

publication date

20 August 2012

1 reference

10 September 2017

1 reference

10 September 2017

volume

4

1 reference

10 September 2017

issue

10

1 reference

10 September 2017

page(s)

1051-6, 1007

1 reference

Anticancer activity of metal complexes: involvement of redox processes

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20072D

Cellular uptake and subcellular distribution of ruthenium-based metallodrugs under clinical investigation versus cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20072D

Recent developments in ruthenium anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20072D

Metal-based antitumour drugs in the post genomic era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20072D

Inhibition of cancer cell growth by ruthenium(II) arene complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20072D

Polynuclear ruthenium, osmium and gold complexes. The quest for innovative anticancer chemotherapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20072D

From bench to bedside--preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A).

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20072D

Primary tumor, lung and kidney retention and antimetastasis effect of NAMI-A following different routes of administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20072D

KP1019, a new redox-active anticancer agent--preclinical development and results of a clinical phase I study in tumor patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20072D

Intracellular protein binding patterns of the anticancer ruthenium drugs KP1019 and KP1339.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20072D

A Phase I and pharmacological study with imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a novel ruthenium anticancer agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20072D

Approaching tumour therapy beyond platinum drugs: status of the art and perspectives of ruthenium drug candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20072D

Comparative binding of antitumor indazolium [trans-tetrachlorobis(1H-indazole)ruthenate(III)] to serum transport proteins assayed by capillary zone electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20072D

Serum-protein interactions with anticancer Ru(III) complexes KP1019 and KP418 characterized by EPR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20072D

Ruthenium-based chemotherapeutics: are they ready for prime time?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20072D

Ruthenium antimetastatic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20072D

Effects of NAMI-A and some related ruthenium complexes on cell viability after short exposure of tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20072D

Biological role of adduct formation of the ruthenium(III) complex NAMI-A with serum albumin and serum transferrin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20072D

Ruthenium complexes can target determinants of tumour malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20072D

Characterization of a ruthenium(III)/NAMI-A adduct with bovine serum albumin that exhibits a high anti-metastatic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20072D

Metabolism of selenite in human lung cancer cells: X-ray absorption and fluorescence studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20072D

X-ray fluorescence microprobe imaging in biology and medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20072D

Selective aggregation of a platinum-gadolinium complex within a tumor-cell nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20072D

Biomedical applications of X-ray absorption and vibrational spectroscopic microscopies in obtaining structural information from complex systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20072D

X-ray absorption and EPR spectroscopic studies of the biotransformations of chromium(VI) in mammalian cells. Is chromodulin an artifact of isolation methods?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20072D

Synthesis, Characterization and Solution Chemistry of trans-Indazoliumtetrachlorobis(Indazole)Ruthenate(III), a New Anticancer Ruthenium Complex. IR, UV, NMR, HPLC Investigations and Antitumor Activity. Crystal Structures of trans-1-Methyl-Indazoliu

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20072D

Antitumour metal compounds: more than theme and variations

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20072D

Silicon nitride as a versatile growth substrate for microspectroscopic imaging and mapping of individual cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20072D

Uptake, distribution, and speciation of selenoamino acids by human cancer cells: X-ray absorption and fluorescence methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20072D

Intracellular mapping of the distribution of metals derived from the antitumor metallocenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20072D

Tumour cell uptake of the metastasis inhibitor ruthenium complex NAMI-A and its in vitro effects on KB cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2MT20072D

21 January 2018

Identifiers

DOI

10.1039/C2MT20072D

1 reference

10 September 2017

1 reference